BRIEF-CTI Biopharma says reacquired worldwide rights to develop, commercialize Pacritinib
October 24, 2016 at 06:28 AM EDT
* Says has reacquired worldwide rights for development and commercialization of Pacritinib
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.